Top

Published in:

01-01-2010 | Case Report

Intradural clival chordoma: a rare pathological entity

Authors: D. I. Bhat, M. Yasha, A. Rojin, S. Sampath, S. K. Shankar

Published in: Journal of Neuro-Oncology | Issue 2/2010

Abstract

Chordomas constitute about 1% of intracranial tumors. They are generally extradural destroying the bone. Intradural chordomas are very rare. We present one such case of a clival intradural chordoma who presented with a left trigeminal nerve sensory neuropathy. The lesion was totally excised uneventfully via a retromastoid suboccipital approach. There was no recurrence of the lesion at 1-year follow-up. Characteristics of intradural chordoma and its close differential ecchordosis physaliphora are reviewed in this article.

Dahlin DC, MacCharty CS (1952) Chordoma: a study of 59 cases. Cancer 5:1170–1178CrossRefPubMed

Erdem E, Angtuaco EC, Van Hemert R, Park JS, Al-Mefty O (2003) Comprehensive review of intracranial chordoma. Radiographic 23:995–1009CrossRef

Mapstone T, Kaufman B, Ratcheson R (1983) Intradural chordoma without bone involvement: nuclear magnetic resonance (NMR) appearance—case report. J Neurosurg 59:535–537CrossRefPubMed

Rubinstein LJ (1972) Tumors of the central nervous system. Atlas of tumor pathology, series 2, fascicle 6. Armed Forces Institute of Pathology, Washington DC, pp 315–318

Rotondo M, Natale M, Mirone G, Cirillo M, Conforti R, Scuotto A (2007) A rare symptomatic presentation of ecchordosis physaliphora: neuroradiological and surgical management. J Neurol Neurosurg Psychiatry 78(6):647–649CrossRefPubMed

Higinbotham NL, Phillips RF, Farr HW et al (1967) Chordoma thirty-five-year study at Memorial Hospital. Cancer 20:1841–1850CrossRefPubMed

Tashiro T, Fukuda T, Inoue Y et al (1994) Intradural chordoma: case report and review of the literature. Neuroradiology 36:313–315CrossRefPubMed

Meyer JE, Oot RF, Lindorfs KK (1986) CT appearance of clival chordomas. J Comput Assist Tomogr 10:34–38CrossRefPubMed

Whelan MA, Reede DL, Meisler W, Bergeron RT (1984) CT of the base of the skull. Radiol Clin North Am 22:177–217PubMed

10.

Oot RF, Melville GE, New PJ et al (1988) The role of MR and CT in evaluating clival chordomas and chondrosarcomas. Am J Roentgenol 151:567–575

11.

Nishigaya K, Kaneko M, Ohashi Y, Nukui H (1998) Intradural retroclival chordoma without bone involvement: no tumor regrowth 5 years after operation—case report. J Neurosurg 88:764–768CrossRefPubMed

12.

Chang SW, Gore PA, Nakaji P, Rekate HL (2008) Juvenile intradural chordoma: case report. Neurosurgery 62(2):E525–E526 (discussion E527)CrossRefPubMed

13.

Ito E, Saito K, Nagatani T, Ishiyama J, Terada K, Yoshida M, Wakabayashi T (2009) Intradural cranial chordoma. Surg Neurol. doi:10.1016/j.surneu.2009.01.003

14.

Mehnert F, Beschorner R, Küker W, Hahn U, Nägele T (2004) Retroclival ecchordosis physaliphora: MR imaging and review of the literature. AJNR Am J Neuroradiol 25(10):1851–1855PubMed

Title: Intradural clival chordoma: a rare pathological entity
Authors: D. I. Bhat
M. Yasha
A. Rojin
S. Sampath
S. K. Shankar
Publication date: 01-01-2010
Publisher: Springer US
Published in: Journal of Neuro-Oncology / Issue 2/2010
Print ISSN: 0167-594X
Electronic ISSN: 1573-7373
DOI: https://doi.org/10.1007/s11060-009-9949-6

At a glance: The STEP trials

Springer Medicine

Intradural clival chordoma: a rare pathological entity

Abstract

At a glance: The STEP trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 2/2010

[11C]-l-Methionine positron emission tomography in the management of children and young adults with brain tumors

PAX6 suppression of glioma angiogenesis and the expression of vascular endothelial growth factor A

Assessment of tumor angiogenesis as a prognostic factor of survival in patients with oligodendroglioma

Induction of matrix metalloproteinase-1 and glioma cell motility by nitric oxide

Management of primary intracranial germ cell tumors

Comparing neuropsychological tasks to optimize brief cognitive batteries for brain tumor clinical trials